{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/48091"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/48091","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Targeting the neuropilin-2 receptor signaling axis","abstract":"Neuropilin-2 (NRP-2), expressed in capillaries and smooth muscle, is involved in a signaling axis featuring both stimulatory and inhibitory pathways. Ligand interaction with NRP-2 determines the effectual pathway: stimulatory VEGF, or inhibitory Semaphorin3. VEGF interaction causes NRP-2 localization with VEGFR-2, while Semaphorin3 (SEMA3) interaction causes NRP-2 to complex with Plexin A. VEGFR-2 interaction induces permeability and angiogenesis, making this an attractive target for anti-angiogenesis treatment. Plexin A interaction induces smooth muscle relaxation, offering a target for treatment of loss of bladder contractility. We aimed to further our understanding of the necessity of NRP-2 in the VEGFR-2-mediated induction of angiogenesis and permeability by performing assays in Nrp-2 knockout (KO) mice. We also tested an inhibitor against Semaphorin3/NRP-2 binding using U87MG cell, a human glioblastoma cell line. Angiogenesis assays were largely inconclusive, but suggested that NRP-2 does play a substantial role in contributing towards vessel growth. Permeability assays showed that NRP-2 plays a significant role in induction of permeability. The Semaphorin3F/NRP-2 inhibitor showed promise as a potential therapeutic, limiting the extent of Semaphorin3-based inhibition of VEGFR-2 pathway.","abstract_html":"Neuropilin-2 (NRP-2), expressed in capillaries and smooth muscle, is involved in a signaling axis featuring both stimulatory and inhibitory pathways. Ligand interaction with NRP-2 determines the effectual pathway: stimulatory VEGF, or inhibitory Semaphorin3. VEGF interaction causes NRP-2 localization with VEGFR-2, while Semaphorin3 (SEMA3) interaction causes NRP-2 to complex with Plexin A. VEGFR-2 interaction induces permeability and angiogenesis, making this an attractive target for anti-angiogenesis treatment. Plexin A interaction induces smooth muscle relaxation, offering a target for treatment of loss of bladder contractility. We aimed to further our understanding of the necessity of NRP-2 in the VEGFR-2-mediated induction of angiogenesis and permeability by performing assays in Nrp-2 knockout (KO) mice. We also tested an inhibitor against Semaphorin3/NRP-2 binding using U87MG cell, a human glioblastoma cell line. Angiogenesis assays were largely inconclusive, but suggested that NRP-2 does play a substantial role in contributing towards vessel growth. Permeability assays showed that NRP-2 plays a significant role in induction of permeability. The Semaphorin3F/NRP-2 inhibitor showed promise as a potential therapeutic, limiting the extent of Semaphorin3-based inhibition of VEGFR-2 pathway.","abstract_has_math":false,"creators":["Ashok, Karthik"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Heaphy, Christopher","Bielenberg, Diane R."],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-19T02:41:58Z","subjects":["Biology","Neuropilin","Neuropilin-2","Semaphorin","Semaphorin3F"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/48091","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/48091","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F48091","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Heaphy, Christopher","Bielenberg, Diane R."]},{"key":"dc:creator","label":"Author","values":["Ashok, Karthik"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-02-15T15:58:36Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2026-02-12T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2023"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2024-02-13T02:04:10Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology","Neuropilin","Neuropilin-2","Semaphorin","Semaphorin3F"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/48091"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Neuropilin-2 (NRP-2), expressed in capillaries and smooth muscle, is involved in a signaling axis featuring both stimulatory and inhibitory pathways. Ligand interaction with NRP-2 determines the effectual pathway: stimulatory VEGF, or inhibitory Semaphorin3. VEGF interaction causes NRP-2 localization with VEGFR-2, while Semaphorin3 (SEMA3) interaction causes NRP-2 to complex with Plexin A. VEGFR-2 interaction induces permeability and angiogenesis, making this an attractive target for anti-angiogenesis treatment. Plexin A interaction induces smooth muscle relaxation, offering a target for treatment of loss of bladder contractility. We aimed to further our understanding of the necessity of NRP-2 in the VEGFR-2-mediated induction of angiogenesis and permeability by performing assays in Nrp-2 knockout (KO) mice. We also tested an inhibitor against Semaphorin3/NRP-2 binding using U87MG cell, a human glioblastoma cell line. Angiogenesis assays were largely inconclusive, but suggested that NRP-2 does play a substantial role in contributing towards vessel growth. Permeability assays showed that NRP-2 plays a significant role in induction of permeability. The Semaphorin3F/NRP-2 inhibitor showed promise as a potential therapeutic, limiting the extent of Semaphorin3-based inhibition of VEGFR-2 pathway."]},{"key":"dc:title","label":"Title","values":["Targeting the neuropilin-2 receptor signaling axis"]}]}],"canonical_facts":{"dc:contributor.advisor":["Heaphy, Christopher","Bielenberg, Diane R."],"dc:creator":["Ashok, Karthik"],"dc:date.accessioned":["2024-02-15T15:58:36Z"],"dc:date.embargo":["2026-02-12T00:00:00Z"],"dc:date.issued":["2023"],"dc:date.updated":["2024-02-13T02:04:10Z"],"dc:description.abstract":["Neuropilin-2 (NRP-2), expressed in capillaries and smooth muscle, is involved in a signaling axis featuring both stimulatory and inhibitory pathways. Ligand interaction with NRP-2 determines the effectual pathway: stimulatory VEGF, or inhibitory Semaphorin3. VEGF interaction causes NRP-2 localization with VEGFR-2, while Semaphorin3 (SEMA3) interaction causes NRP-2 to complex with Plexin A. VEGFR-2 interaction induces permeability and angiogenesis, making this an attractive target for anti-angiogenesis treatment. Plexin A interaction induces smooth muscle relaxation, offering a target for treatment of loss of bladder contractility. We aimed to further our understanding of the necessity of NRP-2 in the VEGFR-2-mediated induction of angiogenesis and permeability by performing assays in Nrp-2 knockout (KO) mice. We also tested an inhibitor against Semaphorin3/NRP-2 binding using U87MG cell, a human glioblastoma cell line. Angiogenesis assays were largely inconclusive, but suggested that NRP-2 does play a substantial role in contributing towards vessel growth. Permeability assays showed that NRP-2 plays a significant role in induction of permeability. The Semaphorin3F/NRP-2 inhibitor showed promise as a potential therapeutic, limiting the extent of Semaphorin3-based inhibition of VEGFR-2 pathway."],"dc:identifier.uri":["https://hdl.handle.net/2144/48091"],"dc:language.iso":["en_US"],"dc:subject":["Biology","Neuropilin","Neuropilin-2","Semaphorin","Semaphorin3F"],"dc:title":["Targeting the neuropilin-2 receptor signaling axis"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:58Z"}